Abstracts - faqs.org

Abstracts

Business, international

Search abstracts:
Abstracts » Business, international

J & J wins $16.6 billion auction for Pfizer consumer-goods unit

Article Abstract:

Johnson & Johnson of the United States is to acquire Pfizer Inc. also of the United States for $16.6 billion. The pharmaceutical house acquisition will increase Johnson & Johnson consumer-products base with the addition of Visine eye drops, Listerine mouthwash and Lubriderm skin cream.

Author: Hemsley, Scott
Publisher: Dow Jones Publishing Co. (Europe)
Publication Name: Wall Street Journal. Europe
Subject: Business, international
ISSN: 0921-9986
Year: 2006
Pfizer Inc., Johnson & Johnson, PFE, JNJ, Company overview

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Reckitt to buy cough-syrup firm

Article Abstract:

UK household products company Reckitt Benckiser PLC has bought US cough medicine manufacturer Adams Respiratory Therapeutics Inc. for $2.3 bil. The deal, at $60 per share, represents a 37% premium and provides Reckitt Benckiser with an entry into the US market.

Author: Shwiff, Kathy, Douglas, Jason
Publisher: Dow Jones Publishing Co. (Europe)
Publication Name: Wall Street Journal. Europe
Subject: Business, international
ISSN: 0921-9986
Year: 2007
Soap and Other Detergent Manufacturing, Soap, Cleaners, and Toilet Goods, Soaps & Detergents, United Kingdom, Soap and cleaning agents industry, Cleaning agents industry, Reckitt Benckiser PLC

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Barr to acquire Croatia's Pliva in a tie-up of generics makers

Article Abstract:

Pliva DD of Croatia is to be acquired by Barr Pharmaceuticals Inc. of the United States for $2.2 billion. Pliva DD is one of the major generic drug makers. Pliva DD share price is up 6.6 percent or $1.47 to $23.95 each on closing in London.

Author: Schwartzkopf, Frances
Publisher: Dow Jones Publishing Co. (Europe)
Publication Name: Wall Street Journal. Europe
Subject: Business, international
ISSN: 0921-9986
Year: 2006
Croatia, BRL, Barr Pharmaceuticals Inc.

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: United States, Pharmaceutical industry, Mergers, acquisitions and divestments, Company acquisition/merger
Similar abstracts:
  • Abstracts: Carlyle's $10 billion puts private equity in hunt for big game. Carlyle, Prudential buy stake in Chinese insurer
  • Abstracts: Mittal Steel offers $3.2 billion for remainder of Arcelor Brasil. Breaking the Marwari rules: Mittal's bid for Arcelor shows how growth brings Indians into conflict with traditions
  • Abstracts: TeliaSonera buys 27% stake in Turkcell for $3.1 billion. Enel's advisers weigh two offers for telecom unit
  • Abstracts: Latest lines cut costs for fish exporters. Machines cut niche products. Intelligent robot loads and grades
  • Abstracts: Alrosa nears deal for Polyus stake. Evraz confirms $2.3 billion deal for Oregon Steel. Abramovich buys 41% stake in Evraz
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.